Saatcioglu F, Lopez G, West B L, Zandi E, Feng W, Lu H, Esmaili A, Apriletti J W, Kushner P J, Baxter J D, Karin M
Department of Pharmacology, Center for Molecular Genetics, School of Medicine, University of California at San Diego, La Jolla 92093-0636, USA.
Mol Cell Biol. 1997 Aug;17(8):4687-95. doi: 10.1128/MCB.17.8.4687.
A short C-terminal sequence that is deleted in the v-ErbA oncoprotein and conserved in members of the nuclear receptor superfamily is required for normal biological function of its normal cellular counterpart, the thyroid hormone receptor alpha (T3R alpha). We carried out an extensive mutational analysis of this region based on the crystal structure of the hormone-bound ligand binding domain of T3R alpha. Mutagenesis of Leu398 or Glu401, which are surface exposed according to the crystal structure, completely blocks or significantly impairs T3-dependent transcriptional activation but does not affect or only partially diminishes interference with AP-1 activity. These are the first mutations that clearly dissociate these activities for T3R alpha. Substitution of Leu400, which is also surface exposed, does not affect interference with AP-1 activity and only partially diminishes T3-dependent transactivation. None of the mutations affect ligand-independent transactivation, consistent with previous findings that this activity is mediated by the N-terminal domain of T3R alpha. The loss of ligand-dependent transactivation for some mutants can largely be reversed in the presence of GRIP1, which acts as a strong ligand-dependent coactivator for wild-type T3R alpha. There is excellent correlation between T3-dependent in vitro association of GRIP1 with T3R alpha mutants and their ability to support T3-dependent transcriptional activation. Therefore, GRIP1, previously found to interact with the glucocorticoid, estrogen, and androgen receptors, may also have a role in T3R alpha-mediated ligand-dependent transcriptional activation. When fused to a heterologous DNA binding domain, that of the yeast transactivator GAL4, the conserved C terminus of T3R alpha functions as a strong ligand-independent activator in both mammalian and yeast cells. However, point mutations within this region have drastically different effects on these activities compared to their effect on the full-length T3R alpha. We conclude that the C-terminal conserved region contains a recognition surface for GRIP1 or a similar coactivator that facilitates its interaction with the basal transcriptional apparatus. While important for ligand-dependent transactivation, this interaction surface is not directly involved in transrepression of AP-1 activity.
v-ErbA癌蛋白中缺失但在核受体超家族成员中保守的短C末端序列,是其正常细胞对应物甲状腺激素受体α(T3Rα)正常生物学功能所必需的。我们基于T3Rα激素结合配体结合域的晶体结构对该区域进行了广泛的突变分析。根据晶体结构,表面暴露的Leu398或Glu401的诱变完全阻断或显著损害T3依赖的转录激活,但不影响或仅部分减少对AP-1活性的干扰。这些是首次能明确区分T3Rα这些活性的突变。同样表面暴露的Leu400的替代不影响对AP-1活性的干扰,仅部分减少T3依赖的反式激活。这些突变均不影响非配体依赖的反式激活,这与之前该活性由T3Rα的N末端结构域介导的发现一致。在存在GRIP1的情况下,一些突变体的配体依赖反式激活的丧失在很大程度上可以逆转,GRIP1对野生型T3Rα起强大的配体依赖共激活剂作用。GRIP1与T3Rα突变体的T3依赖体外结合与其支持T3依赖转录激活的能力之间存在极好的相关性。因此,之前发现与糖皮质激素、雌激素和雄激素受体相互作用的GRIP1,可能在T3Rα介导的配体依赖转录激活中也起作用。当与酵母反式激活因子GAL4的异源DNA结合结构域融合时,T3Rα保守的C末端在哺乳动物和酵母细胞中均作为强大的非配体依赖激活剂发挥作用。然而,与它们对全长T3Rα的影响相比,该区域内的点突变对这些活性有截然不同的影响。我们得出结论,C末端保守区域包含一个GRIP1或类似共激活剂的识别表面,这促进了它与基础转录装置的相互作用。虽然对配体依赖的反式激活很重要,但这种相互作用表面并不直接参与AP-1活性的反式抑制。